Examination of tissue samples of the urogenital tract using optical coherence tomography and other spectrographic means

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011591

Enrollment

Registered

2017-01-13

Start date

2017-01-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant neoplasm of bladder C67

Interventions

Group 1: Patients with scheduled surgical procedures are choosen. Informed consent is obtained. A small part of the tissue specimen which is resected anyway are examined with different OCT- and NBI-pr

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male and female patients and test persons over the age of 18 yrs.

Exclusion criteria

Exclusion criteria: Persons under the age of 18 yrs., pregnant women, emergency patients, persons unable to consent, persons suffering from dementia, disabled persons

Design outcomes

Primary

Measure	Time frame
Feasibility of the probes for the imaging of anatomical and pathological changes in the urogenital tract	—

Countries

Germany

Contacts

Public ContactDominik Schoeb

Klinik für Urologie, Department Chirurgie, Universitätsklinikum Freiburg

Urologie@uniklinik-freiburg.de0761/27028930

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026